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Molluscum contagiosum virus (MCV), a member of the family Poxviridae, replicates well in vivo but cannot be propagated
in cell culture. The coding capacity of the MCV genome was previously determined by DNA nucleotide sequence analysis.
The objective of the present study was to establish experimental systems for the identification and characterization of early
MCV gene transcripts. MCV mRNA was obtained in three ways: (1) MCV early mRNA was synthesized in vitro using
permeabilized virions, (2) MCV mRNA was extracted from MCV-infected skin tissue, and (3) MCV mRNA was extracted from
MCV-infected human embryonic fibroblasts. RNA/DNA hybridization experiments showed significant early transcriptional
activity in two parts of the MCV genome. Transcripts of 11 early MCV genes located in these parts of the genome, including
two subunits of the MCV DNA-dependent RNA polymerase (mc077R and mc079R), the MCV poly(A)1 polymerase gene
(mc076R), and the MCV MHC class I homolog (mc080R), were detected in reverse transcription-polymerase chain reaction
experiments. Total RNA obtained from MCV-infected skin tissue was used to confirm these results. Three MCV early
transcripts, mc002L, mc004.1L, and mc005L, produced distinct bands on rapid amplification of their 39 ends (39 RACE). The
59 mapping of transcription start sites of MCV open reading frames (ORFs) mc002L, mc004.1L, mc005L, and mc148R revealed
that the MCV RNA polymerase transcription start sites are consistently located between 11 and 13 nucleotides downstream
of the early MCV consensus promoter signal. When cDNA from both 59 and 39 mapping experiments was analyzed, MCV
ORFs mc004.1L and mc005L were found to be transcribed as a single bicistronic mRNA. The transcript from MCV ORF
mc066L, encoding a glutathione peroxidase, was detected in in vitro synthesized MCV mRNA as well as in total RNA from
MCV-infected human embryonic fibroblasts and MCV-infected skin. This indicates that despite the lack of an early MCV
consensus promoter signal immediately proximal to the start codon, this particular gene is transcribed early during MCV
infection. © 1999 Academic PressKey Words: molluscum contagiosum virus; DNA nucleotide sequencing; in vitro RNA synthesis; transcription; RT-PCR.
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Molluscum contagiosum (MC) virus (MCV) is a poxvi-
us pathogenic for humans. MCV infection is character-
zed by benign skin tumors that are strictly confined to
he human epidermis, causing little inflammation. MC is
ommon in children and immunocompromised individu-
ls (e.g., HIV-infected patients), where it causes wide-
pread disease and is a marker for late stage cellular
mmunodeficiency. Characterization of the viral proper-
ies has been hindered by the fact that MCV cannot be
ropagated in cell culture. As a first step toward better
nderstanding of the pathogenetic mechanisms of MCV
nfections, the primary structure and coding capacity of
CV were determined by DNA nucleotide sequencing
Senkevich et al., 1996; 1997). The objective of the
resent study was to detect and characterize MCV
RNA transcripts, verify the temporal patterns of MCV
ranscription, and investigate the specific properties of
CV mRNA. Three experimental strategies were used to
chieve these goals.
1 To whom reprint requests should be addressed. Fax: 49-6221-56-
o104. E-mail: j73@ix.urz.uni-heidelberg.de.
119First, in vitro synthesis of MCV mRNA was performed
sing permeabilized virions. Permeabilized poxvirus viri-
ns are able to transcribe 59 capped, polyadenylated,
nd translatable early mRNAs in an ATP-dependent in
itro reaction because they carry a DNA-associated
NA-dependent RNA polymerase, a poly(A)1 polymer-
se, and a capping enzyme in their virion particles. The
RNAs are presumably of the early temporal class be-
ause the MCV virion particles lack full complements of
actors that would be required for transcription of inter-
ediate and late genes (Broyles et al., 1988; Kates and
cAuslan, 1967; Munyon et al., 1967; Shand et al., 1976).
sing this method, we recently characterized the tran-
cript of the molluscum chemokine homolog (MCCH)
ene, a b-chemokine antagonist, that was predicted to
e an early gene based on its conserved poxviral early
romoter signal (Bugert et al., 1998).
Second, total RNA from MCV-infected skin tissue was
nalyzed. The amount and purity of MCV mRNA that can
e obtained from MCV-infected tissue are inferior to the
arly MCV mRNA that is transcribed in vitro. However,
he total RNA from MCV-infected tissues contains inter-
ediate and late transcripts, providing the whole rangef MCV transcripts. MCV-infected tissue total RNA is
0042-6822/99 $30.00
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120 BUGERT, LOHMU¨LLER, AND DARAIherefore suitable for the confirmation of data obtained
ith in vitro early mRNA as well as for control experi-
ents, including late and intermediate MCV mRNA tran-
cripts.
Third, total RNA from human embryonic fibroblasts
hat are infected with MCV was analyzed. In this unique
ystem, MCV induces a cytopathic effect (CPE) 24 h
ostinfection that disappears around 72 h postinfection
Brabanti-Brodano et al., 1974). One can assume that
CV gene expression occurs, and consequently, MCV
RNA must be detectable. The MCV infection is aborted
ecause of a failure to uncoat the viral genome before
NA replication (McFadden et al., 1979).
RESULTS
n vitro transcription and detection of early MCV
RNA transcripts
MCV virions were used to synthesize MCV mRNA in
itro by the virion- associated early transcription com-
lex. The efficiency of permeabilized MC virions to syn-
hesize mRNA in vitro was quantified by a-32P-UTP label-
ng (data not shown; Bugert et al., 1998). Under the
onditions used, a-32P-UTP-labeled MCV mRNA was ex-
ruded into the reaction supernatant. For further experi-
FIG. 1. Southern blot of a-32P-UTP-labeled MCV mRNA against an MC
ecombinant plasmid library: Lambda DNA HindIII digested; molecula
MCV-1-BH-A8 (A8), BamHI–HindIII digested (lane 2), pyMCV-1-E-B, -C
hown in A with a-32P-UTP-labeled MCV mRNA as hybridization probeents with in vitro synthesized MCV mRNA, the super- satant containing the soluble MCV mRNA fraction was
sed. The in vitro synthesized a-32P-UTP-labeled soluble
CV mRNA was used for screening of an MCV-1 DNA
ragment library (Fig. 1A). The labeled MCV mRNA hy-
ridized predominantly to two MCV DNA fragments of
he MCV-1 DNA library: MCV-1 EcoRI fragment F (Fig. 1B,
ane 7) and MCV-1 BamHI–HindIII DNA fragment A8 (a
art of MCV-1 BamHI DNA fragment A, Fig. 1B, lane 2).
Twelve open reading frames (ORFs) with early consen-
us promoters (Figs. 2A and 2B) encoded by these
CV-1 DNA fragments are shown in Fig. 3 and listed in
able 1. Four MCV genes with predicted late promoters
nd one with predicted early promoter (mc148R) were
sed as late negative and early positive controls, respec-
ively (Fig. 2C and Table 1). Oligonucleotide primers
pecific for these MCV genes were synthesized, and the
xpected RT-PCR product lengths are listed in Table 2.
CV transcripts were detected by RT-PCR from MCV
RNA synthesized in vitro and from total RNA isolated
rom MCV-infected skin tissue. The results are shown in
ig. 4 and Table 1.
The results of RT-PCR experiments using in vitro syn-
hesized MCV mRNA are shown in Fig. 4A. With the
xception of ORF mc004L, transcripts from all ORFs
ithin EcoRI DNA fragment F were detectable in in vitro
I DNA fragment library. (A) Slab gel analysis of MCV-1 DNA and MCV-1
hts are given in kbp (m), MCV type 1 DNA HindIII digested (lane 1),
, -F (F), -H, -I EcoRI digested (lanes 3–9). (B) Southern blot of slab gelV EcoR
r weig
, -D, -Eynthesized RNA. In BamHI–HindIII DNA fragment A8,
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121MOLLUSCUM CONTAGIOSUM EARLY TRANSCRIPTIONranscripts from all ORFs with early consensus promot-
rs were detectable in in vitro synthesized MCV mRNA.
Results of the same RT-PCR experiments using MCV-
nfected tissue total RNA are shown in Fig. 4B. The
xperiments with total RNA from MCV-infected tissue
evealed that in this more complex pool of RNA, MCV
ranscripts from ORFs mc076R, mc080R, and mc081R
ere below the threshold of detection. However, tran-
cripts from the other ORFs tested, including ORF
c079R, which encodes the largest subunit of the MCV
NA-dependent RNA polymerase, were detected in total
NA from MCV-infected tissue, indicating that these
RFs were naturally transcribed in vivo.
The positive control amplification products obtained
sing MCV genomic DNA as template are shown in Fig.
C. To exclude DNA contamination of the RNA prepara-
ions, in vitro synthesized MCV mRNA was tested in PCR
xperiments, and the results are shown in Fig. 4D. Nu-
leotide sequence analysis of the RT-PCR products con-
irmed the identity of the amplified MCV cDNA.
ranscription of predicted MCV late genes
Four MCV genes that were predicted to be transcribed
ate based on the analysis of their respective promoter
ignals (Senkevich et al., 1997) were tested by RT-PCR,
nd the results are shown in Table 1 and Fig. 4 (controls).
n these experiments, detection of specific transcripts
as expected only from tissue total RNA because in
FIG. 2. Alignment of MCV promoter sequences and listing of early t
enes encoded by MCV-1 EcoRI DNA fragment F. (B) Promoter sequence
equences of four genes with predicted late promoters: MCV ORFs m
hree-digit number and orientation of transcription (L 5 leftward, R 5 r
f the individual ORFs are aligned, and the distance to the start codon
osition 11. The presence of an early transcription termination signal T
ts absence is noted with a dash.ontrast to in vitro synthesized MCV mRNA, cellular RNA prom MCV-infected skin contains MCV mRNA transcripts
f different temporal classes, including late. However,
nly the transcript of ORF mc066L was detectable by
T-PCR from tissue total RNA (Fig. 4B), confirming that
his gene was transcribed in vivo. Surprisingly, mRNA
ranscripts of MCV ORFs mc 066L and mc110L were
etectable by RT-PCR using in vitro transcribed early
CV mRNA (Fig. 4A)
One possible explanation for the detection of late
ene transcripts in in vitro synthesized mRNA would
e that mRNA classes other than early were tran-
cribed from permeabilized MCV virions. A more or-
hodox explanation is based on an observation made
uring in vitro mRNA transcription of permeabilized
accinia virions. Under the conditions of in vitro mRNA
ynthesis, failure of transcription termination occurs
hen the concentration of ATP is suboptimal in the
eaction mix, causing artificially prolonged mRNA mol-
cules, thus increasing the amount of readthrough
ranscripts (Shuman and Moss, 1989).
To avoid the ATP depletion in in vitro transcription
eactions, RNA from MCV-infected human cells was
ested as an alternative approach for the analysis of MCV
arly transcripts. Human embryonic fibroblasts were in-
ected with purified MCV. A CPE with cell-rounding was
bserved after 20 h that disappeared after 72 h, with full
ecovery of the cell monolayer. Total RNA was extracted
rom MCV-infected cells after 24 h, and RT-PCR was
ption termination signal TTTTTNT (T5NT). (A) Promoter sequences of
nes encoded by MCV-1 BamHI–HindIII DNA fragment A8. (C) Promoter
, mc095R, mc106L, and mc110L. MCV ORFs are identified with their
d). The DNA nucleotide sequences 50 bp upstream of the start codon
n in negative numbers. The first nucleotide of the start codon has the
T (T5NT) is indicated by its distance downstream of the stop codon orranscri
s of ge
c066L
ightwar
is show
TTTTNerformed using primers specific for the MCV ORFs
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122 BUGERT, LOHMU¨LLER, AND DARAIc004L, mc066L, and mc110L. Primers specific for MCV
RF mc148R were used as a positive control. The results
f this experiment are shown in Fig. 5A. Other than
ranscripts from MCV ORF mc148R (Fig. 5A, lane 1), only
ranscripts from MCV ORF mc066L were detected in this
xperiment (Fig. 5A, lane 3). This result indicates that
CV ORF mc066L must be transcribed early, because in
CV-infected human fibroblasts, MCV replication does
ot take place and late poxviral RNA transcripts are not
ade.
Furthermore, transcripts from MCV ORF mc110L were
ot detected, consistent with its late promoter signal (Fig.
A, lane 4). Transcripts from MCV ORF mc095R, another
arly transcription factor subunit, also were not detect-
FIG. 3. Diagram showing the genomic localization of the MCV ORFs
resence of early consensus promoters, and white arrows indicate the
nd 39 RACE amplification products are shown as shaded boxes. T indi
ightward, and inverted T indicates consensus termination sequence
enome indicating the genomic position of EcoRI DNA fragment F and
he MCV-1 genome indicating the genomic position of BamHI–HindIII DN
ndicating the relative position of MCV-1 ORFs mc064R to mc070R and
hat were investigated for readthrough transcription. Shaded arrows in
nvestigate readthrough transcription.ble (Fig. 5A, lane 5). Finally, mRNA transcripts from MCV mRF mc004L were not detectable in this system (Fig. 5A,
ane 2). This confirms previous results from in vitro syn-
hesized MCV mRNA (Figs. 4A and 4B, EcoRI F).
Because readthrough transcription was suspected to
e responsible for the detection of late gene transcripts
n in vitro synthesized MCV mRNA, oligonucleotide prim-
rs upstream and downstream of ORFs mc066L and
c110L were synthesized (Table 2 and Fig. 5B, lanes
–4).
RT-PCR results using in vitro synthesized MCV
RNA (Fig. 5B, lanes 5–8) and total RNA isolated from
CV-infected human fibroblasts (Fig. 5C, lanes 1–4)
ere compared. Fig. 5B, lane 5, shows readthrough
ranscription, presumably from MCV early gene
gated. ORF orientation is shown as arrows. Black arrows indicate the
nce of late consensus promoters. Location and length of PCR probes
onsensus termination sequence (TTTTNT) for early genes transcribed
ly genes transcribed leftward. (A) EcoRI physical map of the MCV-1
sition of MCV-1 ORFs mc002L to mc006L. (B) BamHI physical map of
ment A8 and the position of MCV-1 ORFs mc070R to mc081R. (C) Maps
L to mc112L. Black arrows indicate MCV-1 ORFs mc066L and mc110L
ORFs with early represent location and length of PCR probes used toinvesti
prese
cates c
for ear
the po
A frag
mc108
dicatec064R, located upstream of MCV ORF mc066L using
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123MOLLUSCUM CONTAGIOSUM EARLY TRANSCRIPTIONn vitro synthesized MCV mRNA. However, no RNA
ranscripts were detected from DNA sequences imme-
iately 59 of ORF mc066L (Fig. 5B, lane 6). This ex-
ludes readthrough as the cause for the detection of
ranscripts from mc066L in in vitro synthesized MCV
RNA. Readthrough was detected from upstream and
ownstream early genes in the case of MCV ORF
c110L (Fig. 5B, lanes 7 and 8). This explains the
T-PCR products observed using in vitro synthesized
CV mRNA (Fig. 4A, controls). However, when total
NA isolated from MCV-infected human fibroblasts
as used, no readthrough transcription was detect-
ble at all (Fig. 5C, lanes 1–4), supporting the previous
esults that MCV ORF mc066L is transcribed early.
Taken together, these experiments indicate that the
olluscum glutathione peroxidase gene is transcribed
arly in MCV-infected fibroblasts and that it is tran-
cribed in MCV-infected tissue in vivo. MCV ORF mc110L
s not transcribed early, and readthrough due to failure of
ranscription termination is rare or absent under biolog-
T
Early Genes Encoded by MCV EcoRI DNA Fragment F, B
Viral DNA
ragment (enzyme)
NPa Size (bp)
RT-PCR
Results
Detection
1/2
MC
ORFb NPa
1 mc002L (451) 4849–6201
EcoRI) 1 mc003L (445) 6401–7735
775–11174 2 mc004L (147) 7794–8234
5399) 1 mc004.1L (42) 8331–8456
1 mc005L (85) 8503–8757
1 mc006L (1175) 8801–12,3
8 1 mc070R (93) 86,507–86,7
BamHI/HindIII)d 1 mc076R (343) 90,660–91,6
5,389–98,630
13,241) 1 mc077R (187) 91,591–92,1
1 mc079R (1289) 93,012–96,8
1 mc080R (395) 96,986–98,1
1 mc081R (111) 98,241–98,5
ate gene controls 1 mc066L (220) 83,029–83,6
1 mc110L (707) 130,710–132,
2 mc095R (635) 113,703–115,
2 mc106L (675) 125,313–127,
arly control 1 mc148R (104) 166,992–167,
a Nucleotide position referring to MCV-1 genome complete coding s
b ORF; open reading frame (protein length in amino acids).
c MCV consensus promoter.
d A part of MCV-1 BamHI DNA fragment A (nt 85,389–138,491)cal transcription conditions. a9 and 59 RACE characterization of early MCV
ranscripts
Only three of the MCV early genes investigated have a
oxviral early polyadenylation signal 39 of their coding se-
uences (Fig. 3A). RT-PCR using a gene-specific 59 primer
nd a 39 poly(A)1 detection primer system (Bugert et al.,
998) produced 39 transcript-specific amplification products
f ;650, ;330, ;550, and ; 450 bp for MCV ORFs
c002L, mc004.1L, mc005L, and mc148R, respectively.
heir identity was confirmed by DNA nucleotide sequence
nalysis. As shown in Fig. 6, transcripts were terminated
etween 38 and 118 nucleotides downstream of their re-
pective transcription termination signal TTTTTNT. MCV
RF mc005L has no early poxviral transcription termination
ignal downstream of its stop codon and preceding the
tart codon of MCV ORF mc004.1L. In both 59 and 39 RACE
xperiments, only transcripts including both complete MCV
RFs mc004.1L and mc005L were amplified. The bicis-
ronic transcript is terminated between 87 and 118 nucleo-
ides downstream of the transcription termination signal
HindIII DNA Fragment A8, and Early and Late Controls
es Encoding Hypothetical Viral Proteins
Promoterc Homologies
E Human signaling lymphocyte activating molecule gi
984969 (335; 20.4%)
E Human carcinoembryonic antigen homolog -CGM2
(265; 16.3%)
E mc005L
E
E mc105L (870); VAR-A3L
E Large nonglobular protein, Gln-Ala repeats (Hadasch
et al., 1993)
E VV-L2R (87, 23.7%)
E/L VV-J3R Poly(A)1 polymerase regulatory subunit,
ribose-29-O-methyltransferase
(333, 53.3%)
E/L VV-J4R RNA polymerase subunit
E VV-J6R DNA dependent RNA polymerase largest
subunit
E Human MHC heavy-chain homolog
E/L
L Human glutathione peroxidase (201, 73.8%)
L VV-A7L early transcription factor subunit (710, 59.9%)
L VV-D6R early transcription factor, putative helicase
(637, 74.4%)
L VV-A3L major core protein (644, 57.8%)
E MCV chemokine antagonist (Bugert et al., 1998;
Damon et al., 1998)
e (GenBank accession no. U60315).ABLE 1
amHI/
V Gen
19
85
88
51
78
70
73
88
830
607
337
303
equencfter MCV ORF mc004.1L.
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124 BUGERT, LOHMU¨LLER, AND DARAIThe three genes mc002L, mc005/004.1L, and mc148R,
ith early consensus promoter sequences upstream of
heir start codons (Fig. 3), were used for 59 RACE tran-
T
Primers Used to Analyse MCV Genes Encoded by
DNA Fragment A8, and
MCV ORF
Genome position
(aa)a 59Primer (nucleotide pos
c002L 4849–6201 (451) 59-GCAGCCTGTGCCGGGCACTGCA
(np 5111–5135)
c003L 6401–7735 (445) 59-ACCCCCCACGCCTGCGC-39
(np 6661–6677)
c004L 7794–8234 (147) 59-CGCGACCTCGAGCGTGCACG-3
(np 8041–8060)
c004.1L 8331–8456 (42) 59-ATGTTTCCTGCGGCGCTGCTAC
(np 8432–8456)
c005L 8503–8757 (85) 59-ATGTGTCTTGTGGCGCCGATGC
(np 8733–8757)
c006L 8801–12,319 (1175) 59-TGGTCGCTAGCGAGCGCGCA-3
(np 9078–9097)
c070R 86,507–86,785 (93) 59-ATGATCCGCGACGTCCTAGA-39
(np 86,506–86,526)
c076R 90,660–91,688 (343) 59-CGATTGCTGAGCGTGCACGCGG
(np 91281–91302)
c077R 91,591–92,151 (187) 59-CTGCCCGCGCACAACAAGTTC-3
(np 91,855–91,875)
c079R 93,012–96,878 (1289) 59-GGCCAGCCTGCTCTGCATG-39
(np 96,572–96,590)
c080R 96,986–98,170 (395) 59-CCCCGACTACGACTTTGTGG-39
(np 97,831–97,850)
c081R 98,241–98,573 (111) 59-AGACGCTGGTGATCACGCAC-39
(np 98,251–98,270)
c066L 83,029–83,688 (220)b 59-ATGAACGAGCTGCAGCGG-39
(np 83,452–83,469)
c095R 113,703–115,607 (635) 59-ACCTGCTCGCCGCCATCTACGC
(np 115,115–115,137)
c106L 125,313–127,337 (675) 59-CTAGCAGAAGATCTCGGTGATG
(np 125,310–125,335)
c110L 130,710–132,830 (707) 59-GTACATTCTCATCCAGGAGATCG
(np 131,106–131,130)
c065L Readthrough probe 59-ATGACGGAGCCGCGGCAGTCCG
(np 82,709–82,734)
c065L-066L Readthrough probe 59-ACACATAATTCCGGGCACTAC-3
(np 82,741–82,761)
c109L Readthrough probe 59-ATGGACCGGTTCCGTGCGCTCT
(np 130,542–130,563)
c110L-111L Readthrough probe 59-GCGAGGGCCACCTGCTTGGT-39
(np 132,901–132,919)
c148R 166992–167303 (104) 59-AGGGGCGGAGACGTCTTCGCGA
(np 166,992–167,024)
Oligo dT detection primer 59-ATCG-GAATTC-CTAAAACGACGG
Smart oligonucleotide 59-GTAGGG-GAATTC-AAGCAGTGG
M13 detection primer 59-ATCG-GAATTC-CTAAAACGACGG
c002L 59 RACE 39 gene
specific primer
59-GTAGGG-GAATTC-GAGTCGGTT
c004.1L 59 RACE 39 gene
specific primer
59-GTAGGG-GAATTC-TTGCCCGCT
c005L 59 RACE 39 gene
specific primer
59-GTAGGG-GAATTC-TTAGTCTGCC
a aa, amino acids.
b Genome position and ORF length corrected: Senkevich et al.,
3,029–83,688 (220 amino acids)cription start site mapping. Using a 59 anchor oligonu- bleotide and 39 gene specific primers (Table 2), RT-PCR
as performed, and the amplification products were mo-
ecularly cloned into a bacterial plasmid vector. Recom-
CV-1 EcoRI DNA Fragment F, the BamHI/HindIII
nd Late Control Genes
39Primer (nucleotide position)
Product
length
(bp)
59-TAGCGTAGCATGCTCGTCCCCGTGC-39 289
(np 4861–4885)
59-CGTCATCGACAAGTGCCTCCGCTCC-39 280
(np 6421–6445)
59-GGCGCGCCTACGGGCGGTGCCGCGT-39 270
(np 7801–7825)
59-TTGCCCGCTAGCATGTGTGCCGCAA-39 116
(np 8341–8365)
59-GCCGGCCACTTCTCCGAGAGAGGCT-39 234
(np 8521–8545)
59-CGTACGGCATGGTCTCCAGGCTGGT-39 300
(np 8821–8845)
59-TCACGGGCGCCGCCAGTA-39 279
(np 86,771–86,788)
59-CGCGGGCGCTCGGGCAATGG-39 290
(np 91566–91585)
59-CTACTCGAGCTCGGCCGCCA-39 300
(np 92,135–92,154)
59-CTAAAAGTCCTCCACGTGCGTAGC-39 310
(np 96,858–96,881)
59-GCGCCTGCGGAAGCAAGTTC-39 319
(np 98,313–98,150)
59-CAACGACTAGCGTGCGCAGC-39 270
(np 98,502–98,521)
59-GGGGAGCAGGGCCTCGATGTC-39 417
(np 83,053–83,073)
-39 59-GAGTACAACGTGGGCGCGCCGCTATGA-39 495
(np 115,584–115,610)
59-TCACGATGACGGGCGCGTTCATG-39 600
(np 125,888–125,910)
59-CTAGCTCAGCCGGTAGTAGCGCTC-39 423
(np 130,707–130,730)
39 59-CAAACTGTCGTGCAGCCGCCA-39 293
(np 82,441–82,461)
59-GATCTTGCGTGCCTTCGCCA-39 300
(np 82,991–83,009)
59-AGGAGCGCGCGGAAGAGCTC-39 322
(np 130,241–130,260)
59-TCACTTCTACGGACTCCGGGT-39 258
(np 133,140–133,159)
GTC-39 59-CAGAGACTCGCACCCGGACCATATCTGAGGGC-39
(np 167,272–167,306)
TTTTTTTTTTTTTTTTTTTTTTTTT-39
CGCAGAGTGGCCATTATGGCCGGG-39
-39
GGCAGACACAGAAATG-39
TGTGCCGCAA-39
CCCCTTGCC-39
c066L 83,029–83,469 (211 amino acids) Corrected data: mc066L.ABLE 2
the M
Early a
ition)
TTC-39
9
AAG-39
AGT-39
9
-39
9
GGACT
TTCT-39
TG-39
AGCT-
9
-39
GCGTT
CCAG-
TATCAA
CCAGT
CCCGA
AGCATG
GCTGG
1997: minant clones were analyzed by DNA nucleotide se-
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125MOLLUSCUM CONTAGIOSUM EARLY TRANSCRIPTIONuence analysis. Three to four clones per analyzed MCV
RF were obtained that contained the anchor primer and
he MCV gene transcript-specific cDNA transition se-
uence. The results of the alignments with the 59 un-
ranslated DNA sequences of these genes are shown in
ig. 7. All transcripts started between 11 and 14 nucleo-
ides downstream of the early poxviral consensus pro-
oter sequence. For the MCV ORFs mc004.1L and
c005L, only bicistronic transcripts consisting of both
RFs were observed.
DISCUSSION
Although the disease of MC has been known since
814 (Bateman, 1814), it took almost 150 years to identify
he causing agent as a poxvirus (Dourmaskin and Bern-
ard, 1959). Since then, numerous attempts to cultivate
he virus in vitro have failed, and our knowledge about
he virus–host interactions of this important human dis-
ase is still very limited. The molecular cloning and the
etermination of the primary structure and coding capac-
ty of the MCV genome (Bugert and Darai, 1991; Darai et
l., 1986; Senkevich et al., 1996; 1997) were major steps
n MCV research. The data obtained provide the platform
or further analysis of molecular events during MCV in-
ection.
The first information concerning molecular analysis of
CV transcriptional activity came through the detection
nd characterization of the early mRNA of the molluscum
iral chemokine antagonist (ORF mc148R). This was
FIG. 4. Detection of MCV-1 transcripts by RT-PCR. Analysis of PCR pr
hree-digit number and orientation of transcription. Lanes designated
btained from cDNA using MCV ORF-specific primers and in vitro
RF-specific primers and total RNA derived from MCV-1-infected tiss
ontrols. (D) Negative internal controls in which RNA preparations wechieved by in vitro synthesis of MCV early mRNA and pnalysis of total RNA from MCV-infected tissue (Bugert et
l., 1998). The functional activity of its gene product was
etermined independently through leukocyte migration
nd chemokine receptor binding studies (Damon et al.,
998; Krathwohl et al., 1997). In the present study, we
emonstrate the transcriptional activity of MCV genes
sing in vitro synthesis of mRNA, extraction of MCV
RNA from MCV-infected tissue, and a cell culture sys-
em for the analysis of early MCV transcription products.
Our data indicate that early transcriptional activity oc-
urs over the entire MCV genome. This is in good agree-
ent with previous observations made using in vitro
ranscribed RNA from vaccinia virus and the distribution
f early MCV genes as found during the DNA nucleotide
equence analysis of the MCV genome (Gershowitz et
l., 1978; Senkevich et al., 1996). However, in the case of
CV, early transcription seems to be particularly strong
n two distinct MCV genomic regions: MCV-1 EcoRI DNA
ragment F and BamHI–HindIII DNA fragment A8. This
aises the question of whether genes encoded by these
CV-1 DNA fragments represent a new immediate early
lass of MCV transcripts that might be of special impor-
ance for the early MCV infection. The predicted func-
ions of the MCV early genes concerned include (1)
otential immunodulatory factors (e.g., an MCV homolog
o human lymphocyte signaling antigen and an MCV
HC class I homolog) that may be involved in the down-
egulation of the host NK cell immune answer, and (2)
CV genes associated with transcription [e.g., a
by agarose slab gel electrophoresis. MCV ORFs are indicated by their
) show the 100-bp ladder molecular weight marker. (A) PCR products
ibed viral RNA. (B) PCR products obtained from cDNA using MCV
PCR products obtained from viral DNA serving as positive internal
d by PCR.oducts
with (m
transcr
ue. (C)oly(A)1 polymerase and two DNA-dependent RNA poly-
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126 BUGERT, LOHMU¨LLER, AND DARAIerase subunits]. Clearly, high RNA transcription levels
o not allow predictions regarding the abundance of the
ranslation products. An MCV in vitro infection model,
ust be established in the future that allows the inves-
igation of actual MCV protein expression patterns.
Early poxviral promoter sequences (Davison and
oss, 1989) were found in the majority of the MCV genes
nvestigated (Senkevich et al., 1997). Consequently, we
ere able to detect transcripts by RT-PCR in in vitro
ynthesized MCV mRNA and in RNA from MCV-infected
issue. The latter finding is good evidence that these
enes are transcribed in MCV-infected skin. Transcripts
rom MCV ORF mc004L could not be detected, raising
he possibility that this ORF is only very weakly tran-
cribed or not transcribed at all. The detection of early
ranscripts from MCV ORF mc066L, an MCV glutathione
eroxidase (Shisler et al., 1998), and initially investigated
s MCV late gene control was not expected based on
FIG. 5. Readthrough analysis of MCV ORFs. Analysis of PCR prod-
cts by agarose slab gel electrophoresis. Lanes designated with (m)
how the 100-bp ladder molecular weight marker. (A) PCR products
btained from cDNA using MCV ORF-specific primers and total RNA
solated from MCV-infected human embryonic fibroblasts (MRC5), MCV
RFs mc148R (lane 1), mc004L (lane 2), mc066L (lane 3), mc095R (lane
), mc110L (lane 5), and negative internal controls in which RNA
reparations were tested by PCR (lanes 6–10). (B) DNA positive con-
rols for readthrough probes: Primer-pair mc065L (lane 1), mc066/67
lane 2), mc109L (lane 3), mc110/111 (lane 4), and PCR products ob-
ained from cDNA using readthrough probes and in vitro transcribed
iral RNA (lanes 5–8). (C) PCR products obtained from cDNA using
eadthrough probes and total RNA isolated from MCV-infected human
mbryonic fibroblasts (lanes 1–4).nalysis of its promoter sequence. Looking for possible explanations, we demonstrated that in the in vitro tran-
cription system, readthrough transcription can be ob-
erved leading to the synthesis of polycistronic mRNAs.
his was shown for the bicistronic transcript of MCV
RFs mc005L and mc004.1L. To exclude readthrough as
he cause for the detection of mc066L early transcripts in
itro, MCV transcription products had to be analyzed in
nother transcription system, preferably one that is
ased on MCV infection of human cells. From early
tudies by Brabanti-Brodano et al. (1974) and McFadden
t al. (1979), it seemed likely that only MCV early mRNA
ould be made in MCV-infected human embryonic fibro-
lasts. This assumption was based on the observation
hat a CPE was consistently obtained after MCV infection
f human cells in culture that was attributed to expres-
ion of early MCV gene functions. Replication of MCV
iral DNA was never reported (McFadden et al., 1979),
recluding synthesis of intermediate and late viral
RNAs. Using MCV-infected human fibroblasts, we suc-
eeded in detecting mRNA transcripts from MCV ORF
c066L, leaving early transcription as the only possibility
n the absence of MCV DNA replication. Furthermore,
eadthrough transcription involving MCV ORFs mc066L
nd mc110L was not observed in this system. In the light
f these experiments, the use of MCV-infected human
mbryonic fibroblasts holds great promise for the further
nalysis of early MCV mRNA transcription.
59 RACE experiments on 3 MCV genes with highly
onserved early poxviral consensus promoter se-
uences revealed that the MCV RNA polymerase com-
lex initiated transcription between 11 to 13 nucleotides
ownstream of the respective early poxviral promoter
ignal. These results are in agreement with data ob-
ained from 59 transcript mapping experiments of vac-
inia virus early genes (Coupar et al., 1987; Lee-Chen et
l., 1988). The MCV 39 RACE results are consistent with
revious studies with MCV and vaccinia virus (Bugert et
l., 1998; Yuen and Moss, 1987).
In conclusion, the majority of MCV genes analyzed in
his study is transcribed as predicted by DNA sequence
nalysis of their promoter signals. The MCV glutathione
eroxidase gene (mc066L), which was predicted to be a
ate gene, seems to be transcribed early in the infectious
ycle. This transcription was found to be independent of
eadthrough in MCV-infected human fibroblasts.
MATERIALS AND METHODS
ells, virus, and recombinant plasmids
The MCV-1 isolate HD 94-4 was obtained from an
CV-infected individual and used for the in vitro synthe-
is of MCV mRNA and preparation of infectious virions.
he recombinant plasmids harboring the specific DNA
equences of the MCV-1 prototype used in this study
ere described previously (Bugert and Darai, 1991; Darai
t al., 1986). Human MRC-5 embryonic fibroblasts
(
f
D
6
d
C
I
b
v
a
2
p
m
P
i
c
2
m
1
M
c
F
r
s
1
G
f
a
t
1
t
T
t
s
w
U
i
p
l
t
d
u
a
m
t
p
a
127MOLLUSCUM CONTAGIOSUM EARLY TRANSCRIPTIONCCL171; American Type Culture Collection) were used
or transient infection with MCV. Cells were grown in
MEM with 10% FCS. Infections were carried out in
-well dishes. Each well was infected with an infectious
ose of 0.025 A purified MCV and then incubated until a
PE developed.
n vitro RNA synthesis by permeabilized virions
MCV virions were isolated from MCV lesion material
y centrifugation through a 36% sucrose cushion. The
irions were resuspended in 1 mM Tris–HCl, pH 8.0,
djusted to the absorbance of 1 A260, and stored at
80°C. The in vitro transcription assay is based on a
rotocol described by Shand et al. (1976) and has been
odified for the production of mRNA suitable for RT-
CR. Virus (50 ml) suspension (A260 5 1) was incubated
n a volume of 200 ml with in vitro transcription buffer
ontaining 1.0 M Tris–HCl, pH 8.5, 50 mM MgCl2, 0.25%
-mercaptoethanol, 0.05% Nonidet P-40, 20 ml of 75
M phosphoenolpyruvate, 4.0 mg of pyruvate kinase,
.0 ml of RNasin (40 U/ml; Boehringer-Mannheim,
annheim, Germany), 4.0 mM ATP, and 2.0 mM con-
FIG. 6. Alignment of the DNA nucleotide sequence of the cDNA of t
c148R with the corresponding DNA sequence of the MCV-1 prototy
ranscripts were obtained by 39 RACE from total RNA derived from MCV
CR2.1, and individual clones were analyzed by DNA nucleotide seque
re shown underlined and in bold letters.entration of CTP, UTP, and GTP at 35°C for 120 min. Ror synthesis of radioactively labeled MCV mRNA, the
eaction was incubated for 180 min, and UTP was
ubstituted by 0.2 mM [a-32P]UTP (specific activity,
–3 3 103 Ci/mmol; New England Nuclear, Dreieich,
ermany). Four aliquots (each 20 ml) were taken at dif-
erent times (0, 60, 120, and 180 min); soluble and core
ssociated RNAs were separated by centrifugation, fil-
rated on nitrocellulose, and washed three times with
0% trichloroacetic acid, and the incorporated radioac-
ivity was measured in a Beckman scintillation counter.
he remaining supernatant was phenol/chloroform ex-
racted and ethanol precipitated in the presence of 3.0 M
odium acetate, pH 5.3. Unincorporated nucleotides
ere removed over Sephadex G50 columns. The a-32P-
TP-labeled in vitro transcribed MCV mRNA was hybrid-
zed to MCV and vaccinia viral DNA and recombinant
lasmids harboring MCV viral DNA fragments immobi-
ized on nitrocelluose membranes. Unlabeled in vitro
ranscription reactions were treated under the same con-
itions as described above and used for RT-PCR. Twenty
nits of RNase inhibitor were added to the RNA sample,
nd the reaction was treated with 1.0 ml (40 U/ml) DNase/
nd of MCV-1 early transcripts from ORFs mc002L, mc004.1/005L, and
nBank accession no. U60315). cDNA sequences of MCV chemokine
cted human skin tissue and inserted into the TA site of plasmid vector
Stop codons and poxviral early transcription termination (ETT) signalshe 39 e
pe (Ge
-1-infe
ncing.Nase free.
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128 BUGERT, LOHMU¨LLER, AND DARAINA extraction from MCV-infected human tissue and
CV-infected human fibroblasts
MCV-1-infected human skin samples were immedi-
tely frozen at 220°C. MCV-infected MRC5 cells were
ysed and kept in guanidium isothiocyanate. Total cellu-
ar RNA was extracted from individual MCV lesions and
nfected human embryonic fibroblasts by the guani-
inium/cesium chloride method (Glisin et al., 1974) as
escribed by Sambrook et al. (1989).
T-PCR
Oligonucleotide primers used for PCR were synthe-
ized according to the coding sequences of the respec-
ive MCV-1 ORFs. The properties of the primers used in
his study are summarized in Table 2. PCR was per-
ormed using 0.01 fmol of MCV DNA in 50-ml volumes
ontaining 50 mM KCl, 10 mM Tris–HCl, pH 8.3, 1–2 mM
gCl2, 1.5% formamide, 200 mmol concentration of each
NTP, 200 pmol of each primer, and 0.5 U of Taq Poly-
erase (Perkin–Elmer). Twenty-five cycles were run in an
utomated temperature cycling reactor (Perkin–Elmer
eneamp 2400), which provided 30 s of incubation at
6°C and 4 min at 60°C per cycle. A final incubation step
t 72°C for 7 min was used to extend the unfinished
roducts. The amplified product was phenol/chloroform
xtracted and precipitated in ethanol. For RT-PCR exper-
ments, the AMV reverse transcriptase and the LA Taq
olymerase (TaKaRa-Shuzo Co., Ltd., distributed by
oehringer Ingelheim, Germany) were used. For cDNA
ynthesis, an oligo(dT) primer was designed with an
FIG. 7. Alignment of the DNA nucleotide sequence of the cDNA of the
he corresponding DNA sequence of the MCV-1 prototype (GenBank a
btained by 59 RACE from total RNA derived from MCV-1-infected hum
lasmid vector pCR2.1, and individual clones were analyzed by DNA nu
re shown underlined and in bold letters.niversal M13 primer binding site (Table 2). sapid amplification of MCV transcript 39 ends
39 RACE)
For 39 RACE experiments, an M13 detection primer
ecognized the universal M13 primer binding se-
uence incorporated into the oligo(dT) adapter primer
Table 2). PCR products were analyzed by slab gel
lectrophoresis, and cDNA from RT-PCRs with a spe-
ific product was cloned into the pCR2.1 TA-cloning
ector (InVitrogen). The DNA nucleotide sequence
nalysis of the cDNAs corresponding to the 39 ends of
CV mRNA transcripts was performed using the gene-
pecific 59 primers (Table 2).
apping of MCV transcript 59 ends (59 RACE)
For 59 RACE experiments, an anchor oligonucleotide
Table 2) was attached to MCV transcript 59 ends in the
DNA first-strand reaction using the SMART technology
Switching Mechanism at 59 End of RNA Transcript; Clon-
ech Laboratories, Inc). The MCV transcript 59 ends were
hen PCR amplified using the anchor oligonucleotide as
9 primer and an MCV gene-specific 39 primer. cDNA
rom RT-PCRs with a specific product was cloned into the
CR2.1 TA-cloning vector (InVitrogen). The DNA nucleo-
ide sequence analysis of the cDNAs corresponding to
he 59 ends of MCV mRNA transcripts was performed
sing the gene-specific 39 primers (Table 2).
NA sequence analysis
The DNA sequence of the PCR products in this study
as determined with an automated 373 “Extended” DNA
of MCV-1 early transcripts from ORFs mc002L, 005L, and mc148R with
n no. U60315). cDNA sequences of MCV chemokine transcripts were
tissue using a 59-anchor oligonucleotide, inserted into the TA site of
e sequencing. MCV consensus promoter sequences and start codons59 end
ccessio
an skin
cleotidequencer using the standard terminator cycle sequenc-
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129MOLLUSCUM CONTAGIOSUM EARLY TRANSCRIPTIONng technique (Applied Biosystems GmbH, Perkin–Elmer
orporation, Germany).
omputer-assisted sequence analysis
Nucleotide sequences were compiled using the ABI
equence navigator software version 1.2. Nucleotide
nd amino acid sequences were analyzed using the
CGENE program release 6.85 (Intelligenetics Inc.,
ountain View, CA), Omiga release 1.1, and the NIH
LAST server (http://www.ncbi.nlm.nih.gov/cgi-bin/
LAST/).
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